MP:0000239 | deficiency of myeloid colony forming progenitor cells | "lack of precursors of the myeloid cell types" [J:60630, tc:Teresa Chu , Mouse Genome Informatics Curator] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
|
MP:0000333 | decreased bone marrow cell number | "decreased number of cells that make up the core cavities of bones when compared to the norm" [tc:Teresa Chu , Mouse Genome Informatics Curator, J:60896] |
Show
Allelic Composition: Prss16tm1Mal/Prss16+,Rag2tm1Fwa/Rag2tm1Fwa,Tg(TcraH-Y,TcrbH-Y)1Pas/? Genetic Background: involves: 129S/SvEv * 129S2/SvPas * C57BL/6
|
MP:0000596 | abnormal liver development | "anomalous differentiation of the liver" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Knk/Adar+ Genetic Background: chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
MP:0000598 | abnormal liver morphology | "malformation or absence of this bile-secreting exocrine gland, which is important for detoxification; for fat, carbohydrate, and protein metabolism; and for glycogen storage " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:CLS, J:23170] |
Show
Allelic Composition: Adartm1.1Knk/Adartm1.1Knk Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|
MP:0000600 | liver hypoplasia | "reduced size of liver due to decreased cell number " [J:57631] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
|
MP:0000601 | small liver | "reduced size of the liver" [J:23170] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
|
MP:0001258 | decreased body length | "decreased crown to tail distance compared to controls" [cwg:Carroll W. Goldsmith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pax3Sp-2J/Pax3Sp-2J Genetic Background: either: C3H/HeJ-Pax3Sp-2J or (involves: C3H/HeJ * C57BL/6J)
|
MP:0001265 | reduced body size | "smaller than average body weight, height and/or length of an organism compared to controls" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:23170] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0001556 | increased circulating HDL cholesterol level | "higher than average level of high density lipoprotein in the blood; this molecule transports cholesterol to the liver for excretion in bile" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:47439] |
Show
Allelic Composition: Pax3Sp-2J/Pax3Sp-2J Genetic Background: either: C3H/HeJ-Pax3Sp-2J or (involves: C3H/HeJ * C57BL/6J)
|
MP:0001559 | hyperglycemia | "abnormally high concentration of glucose in the blood; generally refers to a pathological state" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0001570 | abnormal circulating enzyme level | "aberrent concentration in the blood of any of the proteins that act as catalysts for biological reactions" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0001606 | impaired hematopoiesis | "atypical process of blood cell formation with the result of fewer of these cells being formed" [tc:Teresa Chu , Mouse Genome Informatics Curator, J:60896] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
|
MP:0001648 | abnormal apoptosis | "excessive or absent cell death in a particular tissue or cell type" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:cls, J:25248] |
Show
Allelic Composition: Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0001697 | abnormal embryo size | "anomalous proportions of embryo compared to littermates" [cwg:Carroll W. Goldsmith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pax3Sp-2J/Pax3Sp-2J Genetic Background: either: C3H/HeJ-Pax3Sp-2J or (involves: C3H/HeJ * C57BL/6J)
|
MP:0001722 | pale yolk sac | "bloodless yolk sac" [J:62571] |
Show
Allelic Composition: Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0001914 | hemorrhage | "loss of blood from the vascular compartment to the exterior or into nonvascular body space as a result of rupture or severance of the blood vessels" [Stedman s Medical Dictionary, 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0002123 | abnormal hematopoiesis | "abnormal development of the enucleated fetal and adult erythrocytes that develop in the aorta, genital ridge and mesonephros region and later in the fetal and adult liver" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Akt3Nmf350/Akt3+ Genetic Background: C57BL/6J-Akt3Nmf350
|
MP:0002941 | increased circulating alanine transaminase level | "increased concentration in the blood of this enzyme, which transfers amino groups from l-alanine to 2 ketoglutarate, or the reverse (from l-glutamate to pyruvate); serum concentration is increased in viral hepatitis and myocardial infarction" [pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0002944 | increased lactate dehydrogenase level | "greater than the normal concentration of this enzyme, which catalyzes the interconversion of lactate and pyruvate" [pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator, J:87714] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0002968 | increased circulating alkaline phosphatase level | "elevated activity of this enzyme, which hydrolyzes orthophosphoric monoesters, found in the blood" [RGD:Rat Genome Database submission, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0003717 | pallor | "an unnatural paleness to the skin, generally attributable to anemia" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0003720 | abnormal neural tube closure | "abnormal invagination and fusion of the neuroepithelial layer in early development" [monikat:Monika Tomczuk, Mouse Genome Informatics Curator, J:99099] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0003795 | abnormal bone structure | |
Show
Allelic Composition: Pax3Sp-2J/Pax3Sp-2J Genetic Background: either: C3H/HeJ-Pax3Sp-2J or (involves: C3H/HeJ * C57BL/6J)
|
MP:0003887 | increased hepatocyte apoptosis | "increase in the number of hepatocytes undergoing programmed cell death" [anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0003984 | embryonic growth retardation | "slow or limited development before birth" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
|
MP:0004229 | abnormal embryonic erythropoiesis | "anomaly in the development of primarily large, nucleated erythroblasts occurring in blood islands in the yolk sac, generally occurs from E7-E11 in the mouse and through 10 weeks in humans" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Adartm2Knk/Adar+ Genetic Background: chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
MP:0004258 | abnormal placenta size | "anomaly in the size or shape of the organ of metabolic interchange between fetus and mother" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0004808 | abnormal hematopoietic stem cell morphology | "any structural anomaly of the multipotent, self-renewing stem cells found in the bone marrow and the fetal liver; these give rise to all the types of both the myeloid and lymphoid cell lineages" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
Allelic Composition: Adartm1.1Phs/Adartm2Phs,Tg(Tal1-cre/ERT)42-056Jrg/? Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
MP:0005343 | increased circulating aspartate transaminase level | "greater than normal concentration in the blood of this enzyme, which catalyzes the reversible transfer of an amine group from l-glutamic acid to oxaloacetic acid, forming alpha-ketoglutaric acid and l-aspartic acid; aids in diagnosis of viral hepatitis and myocardial infarction" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator, J:85204] |
Show
Allelic Composition: Adartm1Knk/Adartm1Knk,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
|
MP:0005621 | abnormal cell physiology | "aberration in the vital processes of the cell " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, hdene:Howard Dene , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Akt3Nmf350/Akt3+ Genetic Background: C57BL/6J-Akt3Nmf350
|
MP:0008550 | abnormal circulating interferon-beta level | "anomaly in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
|
MP:0008573 | increased circulating interferon-alpha level | "increase in the amount in the blood of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
|
MP:0008943 | increased sensitivity to induced cell death | "decrease in the exposure level to an agent that is required to induce cessation of function at the cellular level" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0010124 | decreased bone mineral content | "reduction in the amount (usually in grams/cm) of bone mineral divided by a bone-scanned area" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pax3Sp-2J/Pax3Sp-2J Genetic Background: either: C3H/HeJ-Pax3Sp-2J or (involves: C3H/HeJ * C57BL/6J)
|
MP:0011085 | complete postnatal lethality | "premature death anytime between the neonatal period and weaning age of all organisms of a given genotype in a population (Mus: P1 to approximately 3 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Plp1tm1Frca/Y Genetic Background: B6.129-Plp1tm1Frca
|
MP:0011098 | complete embryonic lethality during organogenesis | "death of all organisms of a given genotype in a population between embryo turning and the completion of organogenesis (Mus: E9 to less than E14)" [MGI:csmith] |
Show
Allelic Composition: KitW-57J/Kit+ Genetic Background: involves: C58/J
Allelic Composition: Adartm1Phs/Adartm1Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Allelic Composition: Adartm2Phs/Adartm2Phs Genetic Background: involves: 129S1/Sv * 129X1/SvJ * NMRI
Allelic Composition: Adartm1.1Knk/Adartm1.1Knk Genetic Background: involves: 129S1/Sv * 129X1/SvJ
Allelic Composition: Adartm1Olds/Adartm1Olds Genetic Background: involves: 129S/SvEv * C57BL/6J
Allelic Composition: Adartm2Knk/Adar+ Genetic Background: chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
MP:0011100 | complete preweaning lethality | "death of all organisms of a given genotype in a population between fertilization and weaning age (Mus: approximately 3-4 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0013292 | embryonic lethality prior to organogenesis | "death prior to the completion of embryo turning (Mus: E9-9.5)" [MGI:smb] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0013293 | embryonic lethality prior to tooth bud stage | "death prior to the appearance of tooth buds (Mus: E12-E12.5)" [MGI:smb] |
Show
Allelic Composition: Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi Genetic Background: B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
|
MP:0013504 | increased embryonic tissue cell apoptosis | "increase in the timing or the number of cells in embryonic tissue undergoing programmed cell death" [MGI:csmith] |
Show
Allelic Composition: Adartm1.1Knk/Adartm1.1Knk Genetic Background: involves: 129S1/Sv * 129X1/SvJ
|